VICINITAS THERAPEUTICS
Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives. Its vision is to use its proprietary Deubiquitinase Targeting Chimera (DUBTAC) platform to restore the levels of aberrantly degraded proteins that cause disease to confer therapeutic benefit.
VICINITAS THERAPEUTICS
Industry:
Biotechnology Life Science Therapeutics
Founded:
2022-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.vicinitastx.com
Status:
Active
Total Funding:
65 M USD
Technology used in webpage:
Google Analytics Apache Google Analytics Classic Unified Layer CentOS Apache 2.2 BlueHost
Current Advisors List
Investors List
Berkeley Catalyst Fund (BCF)
Berkeley Catalyst Fund (BCF) investment in Series A - Vicinitas Therapeutics
The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research investment in Series A - Vicinitas Therapeutics
Droia Ventures
Droia Ventures investment in Series A - Vicinitas Therapeutics
GV
GV investment in Series A - Vicinitas Therapeutics
Andreessen Horowitz
Andreessen Horowitz investment in Series A - Vicinitas Therapeutics
Deerfield
Deerfield investment in Series A - Vicinitas Therapeutics
Official Site Inspections
http://www.vicinitastx.com Semrush global rank: 7.84 M Semrush visits lastest month: 432
- Host name: server-18-160-10-61.iad12.r.cloudfront.net
- IP address: 18.160.10.61
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Loading ... 